Skip to main content
. 2012 May;50(5):1769–1772. doi: 10.1128/JCM.06723-11

Table 1.

Sensitivity, linearity, and precision results for the ART assay

Specimen source Nominal VL (log10 IU/ml)a No. tested No. detectable Mean (SD) VL (log10 IU/ml) CV (%)
Panelb 0 3 0 Target not detected
1.04 12 10 <1.08c
1.52 12 12 1.26 (0.17)d 13.9
2.20 12 12 1.63 (0.11) 6.7
2.79 9 9 2.21 (0.08) 3.8
3.67 9 9 3.23 (0.13) 4.0
4.71 9 9 4.29 (0.05) 1.1
5.28 9 9 4.81 (0.07) 1.4
5.72 9 9 5.29 (0.07) 1.4
6.73 9 9 6.38 (0.09) 1.5
Patiente 0.89 5 5 <1.08c
1.89 5 5 1.66 (0.1) 5.9
2.89 5 5 2.65 (0.08) 2.9
3.89 5 5 3.68 (0.04) 1.2
4.89 5 5 4.68 (0.11) 2.3
5.89 5 5 5.72 (0.09) 1.5
6.89 3 3 6.61 (0.005) 0.1
7.89 5 5 7.89 (0.03) 0.4
a

For the panel specimens, the assay-specific nominal VL (provided by the manufacturer) was used; for the patient dilution series, the reported nominal viral load is the mean of experimental values for undiluted replicates.

b

Specimens from the SeraCare panel (see Materials and Methods); nominal VL values are based on the manufacturer's results with the ART assay.

c

All results were above the limit of detection but below the limit of quantitation.

d

Mean of 7 results above the limit of quantitation.

e

Serial 10-fold dilutions of a patient specimen with a high viral load; the nominal VL was calculated by averaging all VL results (n = 5) from the undiluted specimen (7.89 log10 IU/ml) and adjusting for the dilution factor.